10-Q – Page 135 – China Stock Advice

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. PART I.FINANCIAL INFORMATION Item 1.ndensednsolidated Financial Statements 3ndensednsolidated Balance Sheets of March 31, 2013 (unaudited) and December 31, 2012 3ndensednsolidated Statements ofmprehensiveome for the Three Months Ended March 31, 2013 and 2012 (unaudited) 4ndensednsolidated Statements ofsh Flows for the Three Months Ended March 31, 2013 and 2012(unaudited)] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. May 15, 2013 Weibing Lu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. May 15, 2013 Bing Mei Chief Financial Officer]

By info| 2016-02-05T02:58:01+00:00 May 15th, 2013|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 10-Q, 2013-05-15, 2834, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x March 31, 2013 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 14, 2013 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321033113.htm]

By info| 2016-03-03T16:56:27+00:00 May 14th, 2013|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q, 2013-05-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x March 31, 2013

[FORM 10-Q (Mark One) x March 31, 2013 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 14, 2013 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321033113.htm]

By info| 2016-03-03T16:57:38+00:00 May 14th, 2013|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q, 2013-05-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x March 31, 2013 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Nevada 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:May 14, 2013 President and Chief Executive Officer (principal financial officer and principal accounting officer) cphi10qex321033113.htm]

By info| 2016-02-07T21:39:50+00:00 May 14th, 2013|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q, 2013-05-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x March 31, 2013

[FORM 10-Q (Mark One) x March 31, 2013 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Nevada 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:May 14, 2013 President and Chief Executive Officer (principal financial officer and principal accounting officer) cphi10qex321033113.htm]

By info| 2016-02-07T21:40:28+00:00 May 14th, 2013|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q, 2013-05-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

KNDI [Kandi Technologies] 10-Q: (Original Filing)

[FORM 10-Q [ x ] For the quarterly period ended March 31, 2013 or [ ] For the transition period from ______to______ KANDI TECHNOLOGIES GROUP, INC. Delaware 90-0363723 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) Post Code 321016 Jinhua City Industrial Zone (86 - 579) 82239856 Large accelerated filer [ ] Accelerated filer [ ]] [The Joint Venture Agreement of Establishment of Zhejiang Kandi Electric Vehicles Co., Ltd. by Shanghai Maple Guorun Automobile Co., Ltd., a subsidiary of and Zhejiang Kandi Vehicles Co., Ltd., a subsidiary of Kandi Technologies Group, Inc. Nasdaq: KNDI March 22, 2013 1 Table of Contents 1. Parties of the Joint Venture 7 1.1 Parties of the Joint Venture 7 1.2] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Hu Xiaoming, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Zhu Xiaoying, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. § 1350, § 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.]

By info| 2016-03-18T13:51:43+00:00 May 14th, 2013|Categories: Chinese Stocks, KNDI, SEC Original|Tags: 0001316517, 10-Q, 2013-05-14, 3711, KNDI, MOTOR VEHICLES and PASSENGER CAR BODIES|0 Comments

KNDI [Kandi Technologies] 10-Q: FORM 10-Q [ x ] For the quarterly

[FORM 10-Q [ x ] For the quarterly period ended March 31, 2013 or [ ] For the transition period from ______to______ KANDI TECHNOLOGIES GROUP, INC. Delaware 90-0363723 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) Post Code 321016 Jinhua City Industrial Zone (86 - 579) 82239856 Large accelerated filer [ ] Accelerated filer [ ]] [The Joint Venture Agreement of Establishment of Zhejiang Kandi Electric Vehicles Co., Ltd. by Shanghai Maple Guorun Automobile Co., Ltd., a subsidiary of and Zhejiang Kandi Vehicles Co., Ltd., a subsidiary of Kandi Technologies Group, Inc. Nasdaq: KNDI March 22, 2013 1 Table of Contents 1. Parties of the Joint Venture 7 1.1 Parties of the Joint Venture 7 1.2] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Hu Xiaoming, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Zhu Xiaoying, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. § 1350, § 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.]

By info| 2016-03-18T13:52:45+00:00 May 14th, 2013|Categories: Chinese Stocks, KNDI, Webplus ver|Tags: 0001316517, 10-Q, 2013-05-14, 3711, KNDI, MOTOR VEHICLES and PASSENGER CAR BODIES|0 Comments

CXDC [China XD Plastics Co] 10-Q: (Original Filing)

[TABLE OF CONTENTS PAGE PART I. FINANCIAL INFORMATION 2] [CERTIFICATION I, Jie Han, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Taylor Zhang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION Jie Han, Chief Executive Officer] [CERTIFICATION Taylor Zhang, Chief Financial Officer (Princiapl Financial and Accounting Officer)]

By info| 2016-03-25T15:31:45+00:00 May 14th, 2013|Categories: Chinese Stocks, CXDC, SEC Original|Tags: 0001353970, 10-Q, 2013-05-14, 3086, CXDC, PLASTICS FOAM PRODUCTS|0 Comments

CPGI [China Shengda Packaging] 10-Q: (Original Filing)

[FORM 10−Q (Mark One) March 31, 2013 For the quarterly period ended: For the transition period from _____________ to _____________ 001-34997 CHINA SHENGDA PACKAGING GROUP INC. Nevada 26-1559574 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) No. 2 Beitang Road Xiaoshan Economic and Technological Development Zone Hangzhou, Zhejiang Province 311215 Peoples Republic of China (86) 571-82838805] [CERTIFICATIONS I, Daliang Teng, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Shengda Packaging Group Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ken He, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Shengda Packaging Group Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. Daliang Teng Chief Executive Officer] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. Ken He Chief Financial Officer (Principal Financial Officer)]

By info| 2016-03-08T20:45:58+00:00 May 14th, 2013|Categories: Chinese Stocks, CPGI, SEC Original|Tags: 0001421561, 10-Q, 2013-05-14, 2650, CPGI, PAPERBOARD CONTAINERS and BOXES|0 Comments

CXDC [China XD Plastics Co] 10-Q: TABLE OF CONTENTS PAGE PART I. FINANCIAL INFORMATION

[TABLE OF CONTENTS PAGE PART I. FINANCIAL INFORMATION 2] [CERTIFICATION I, Jie Han, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Taylor Zhang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION Jie Han, Chief Executive Officer] [CERTIFICATION Taylor Zhang, Chief Financial Officer (Princiapl Financial and Accounting Officer)]

By info| 2016-03-25T15:32:38+00:00 May 14th, 2013|Categories: Chinese Stocks, CXDC, Webplus ver|Tags: 0001353970, 10-Q, 2013-05-14, 3086, CXDC, PLASTICS FOAM PRODUCTS|0 Comments